Senior insider sale
Chief Financial Officer at VIKING THERAPEUTICS, INC. — senior position signals high conviction
$261.0K
15K shares
What this filing means
ZANTE GREG plans to sell 15K shares of VIKING THERAPEUTICS, INC. valued at approximately $261.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/4/2024ACC: 0001217234-24-000004
Officer· Chief Financial Officer
Since Jan 2021
15K
Shares to sell
$261.0K
Approx. market value
15K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
RSU Vesting
N/A
1/4/2024
15KTotal acquired15K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/4/2024 | RSU Vesting N/A | 15K | — |
| Total | 15K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
15K
Market value
$261.0K
1/4/2024
Total
Units
15K
Value
$261.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
1/4/2024 | 15K | $261.0K | Nasdaq | Planned |
| Total | 15K | $261.0K | ||